by adminAdrianRamirez | Jun 1, 2018 | Kannalife Sciences, Media Coverage
Medical Marijuana, Inc. companies Kannalife™ Sciences, Kannaway, and HempMeds® were included in media coverage of the cannabis industry this week. Medical Marijuana, Inc. achievements like our three months of record growth to begin the year, the creation of a CBD-like...
by adminAdrianRamirez | May 25, 2018 | Kannalife Sciences, Kannaway, Media Coverage
Portfolio companies Phyto Animal Health, Kannaway, and Kannalife™ Sciences make headlines this week as part of the booming CBD industry. Medical Marijuana, Inc.’s incredible growth to begin 2018 was prime among the notable developments from our portfolio covered by...
by adminAdrianRamirez | May 22, 2018 | Kannalife Sciences, Press Releases
SAN DIEGO, May 22, 2018 — Medical Marijuana, Inc. (OTC:MJNA) announced today that portfolio company Kannalife Sciences, Inc. (“Kannalife”), a bio-pharmaceutical and phyto-medical company, was featured in a Dateline NBC segment discussing how their...
by adminAdrianRamirez | May 18, 2018 | HempMeds, Kannalife Sciences, Kannaway, Media Coverage
A pair of Medical Marijuana, Inc. spokespeople and former NFL players were interviewed for national media outlets this week. Medical Marijuana, Inc. portfolio companies Hempmeds®, Kannaway, and Kannalife™ Sciences and their spokespersons were included in stories on...
by adminAdrianRamirez | Nov 21, 2017 | Kannalife Sciences, Media Coverage, Uncategorized
The former NFL player and current Kannalife™ Sciences spokesman talked about the efforts to develop a cannabinoid-based treatment for CTE, a disease plaguing players in the NFL. Kannalife™ Sciences spokesperson Nick Lowery was recently invited to the Reiter Than You...
by adminAdrianRamirez | Nov 1, 2017 | Kannalife Sciences, Media Coverage
Former National Football League (NFL) player and current KannalifeTM Sciences spokesperson Nick Lowery recently visited with Kansas City’s Between the Lines radio show to discuss the current state of the NFL and how hemp-derived cannabidiol (CBD) treatments may play a...